NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

Cell Death Discovery, published by Springer Nature, is a distinguished open-access journal dedicated to advancing the field of cell death research. Since its inception in 2015, the journal has rapidly established itself as a premier platform for high-quality research, currently holding a remarkable position in the Q1 quartiles across multiple categories, including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, and Immunology. With an impact factor reflecting its significant contribution to the scientific community, Cell Death Discovery invites submissions that explore the molecular mechanisms of cell death and its implications across various biomedical fields. The journal's open-access model ensures that groundbreaking research is accessible to a global audience, facilitating collaboration and dissemination among researchers, professionals, and students alike. Located in the UK, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, the journal continues to support innovative scholarship and foster a deeper understanding of the processes behind cell viability, development, and disease.

REDOX REPORT is a peer-reviewed academic journal published by Taylor & Francis Ltd, focusing on the latest advancements in the fields of biochemistry, clinical biochemistry, and physiology. Since its inception in 1996 and transitioning to an Open Access model in 2018, this journal has aimed to disseminate high-quality research findings and foster discussions within the scientific community. Positioned in the Q2 quartile across several relevant categories, including Biochemistry, Cell Biology, and Clinical Biochemistry, REDOX REPORT is recognized for its commitment to impactful research. The journal plays a crucial role in bridging the gap between fundamental biochemical research and its clinical applications, making it an essential resource for researchers, professionals, and students alike. With a consistent publication record extending to 2024, REDOX REPORT is dedicated to featuring cutting-edge studies that advance our understanding of redox biology, thereby contributing significantly to the ongoing dialogue in the life sciences.

FRONTIERS IN NEUROENDOCRINOLOGY, published by Academic Press Inc, Elsevier Science, is a leading peer-reviewed journal dedicated to advancing the understanding of neuroendocrinology, focusing on the intricate interactions between the nervous system and endocrine functions. Established in 1973, this esteemed publication has consistently demonstrated its significance in the field, achieving a category quartile ranking of Q1 in Endocrine and Autonomic Systems for 2023, and securing a remarkable 93rd percentile in the Scopus Rankings. Though the journal is not open-access, it is widely recognized for its high-quality research articles that provide crucial insights into the neuroendocrine mechanisms underlying various physiological processes and disorders. As it continues to bridge gaps in knowledge from 1990 through to 2024, FRONTIERS IN NEUROENDOCRINOLOGY is essential for researchers, professionals, and students alike, aiming to foster collaboration and innovation within the dynamic landscape of neuroendocrine science.

NEUROCHEMICAL RESEARCH, published by Springer/Plenum Publishers, is a pivotal journal in the fields of biochemistry, neuroscience, and cellular and molecular studies. With an impressive impact factor that positions it within the prestigious Q1 category in Biochemistry and Medicine and Q2 in Cellular and Molecular Neuroscience, it provides a robust platform for the dissemination of cutting-edge research findings. Since its inception in 1976, the journal has played a crucial role in bridging the gap between neurochemical processes and neurological health, making significant contributions to our understanding of brain function and disease. Researchers and professionals are encouraged to engage with a wealth of high-quality articles that not only advance the field but also inform clinical practices. Located in the heart of New York, the journal continues to uphold its reputation as a leader in promoting innovative research that is essential for both academic and applied sciences.

Neurobiology of Learning and Memory is a prestigious journal dedicated to the exploration of the neural mechanisms underlying learning and memory processes. Published by Academic Press Inc Elsevier Science, this journal boasts a strong reputation within the field, as evidenced by its impressive impact factor and high quartile rankings in multiple categories, including Q1 in Behavioral Neuroscience and Q2 in Cognitive Neuroscience. Having provided a platform for groundbreaking research since its inception in 1995, the journal aims to disseminate influential findings that further our understanding of cognitive processes, shaped by robust empirical studies and theoretical developments. Researchers and professionals in neuroscience, psychology, and related disciplines will find invaluable insights and advancements that underscore the journal's commitment to fostering knowledge and innovation within these fields. While it currently operates under a subscription model, its comprehensive coverage of crucial topics positions it as a vital resource for those engaged in the intricate study of learning and memory.

NEUROSCIENTIST is a leading journal in the field of clinical neurology and neuroscience, published by SAGE Publications Inc. With an impressive impact factor reflected in its Q1 quartile ranking in both clinical neurology and miscellaneous neuroscience as of 2023, this journal positions itself as a crucial platform for the latest research and advancements in the neural sciences. Spanning from 1995 to 2024, NEUROSCIENTIST features a range of high-quality, peer-reviewed articles that cater to researchers, practitioners, and students alike. Although it does not offer Open Access options, the journal remains a vital resource owing to its Scopus rankings, situating it within the top percentile of its categories: ranked #28 out of 400 in clinical neurology and #15 out of 113 in general neuroscience. The journal's commitment to disseminating significant findings underlines its importance in fostering advancements in neurological understanding and treatment.

STRESS - THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS, published by Taylor & Francis Ltd, is an esteemed open-access journal dedicated to advancing our understanding of stress and its biological underpinnings. Established in 1996 and continuing until 2024, this journal is pivotal in the exploration of stress across multiple dimensions, including its impact on mental health, neurobiology, and endocrine systems. With an impressive categorization in Q2 and Q3 quartiles across various fields such as Behavioral Neuroscience, Psychiatry, and Physiology, STRESS ranks commendably within its discipline, positioning itself as a vital resource for researchers and professionals alike. As of 2022, the journal's open access policy enhances visibility and accessibility, fostering a broader dissemination of knowledge. The journal invites submissions from a diverse range of disciplines, aiming to bridge gaps across fields and encourage interdisciplinary collaboration. By addressing the multifaceted nature of stress, STRESS remains essential for those eager to contribute to this dynamic and critical area of research.

Heart and Mind, published by Wolters Kluwer Medknow Publications, is a distinguished open access journal that has been serving the fields of Cardiology, Clinical Psychology, Neurology, and Psychiatry since its inception in 2017. With an ISSN of 2468-6476 and an E-ISSN of 2468-6484, this journal aims to bridge the rapidly evolving intersection between cardiovascular health and mental well-being. Based in India, it has gained recognition reflected by its Category Quartiles standing in Q3 across multiple disciplines, demonstrating its relevance and contribution to ongoing research. Researchers, healthcare professionals, and students will find Heart and Mind a valuable resource, as it facilitates access to critical insights and innovative studies within these interconnected fields. The journal’s commitment to open access ensures that vital findings and advancements are available to a global audience, fostering collaboration and knowledge-sharing to advance healthcare practices. Emphasizing high-quality research, Heart and Mind continually strives to elevate the understanding of cardiovascular and mental health, making it a pivotal platform for contemporary academic discourse.

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.